Abstract
Recent observations revealed a novel role of angiotensin-converting enzyme 2 and the angiotensin II type-1 receptor (AT1R) in lung injury, thereby extending knowledge about the functions of the angiotensin system. Angiotensin II, whose target is the AT1R, is a potent vasoconstrictor. Accordingly, an imbalance leading to enhanced activity of the angiotensin II-AT1R axis is postulated to contribute to both circulatory disturbances and lung injury. In this context, a functional single-nucleotide polymorphism, AT1R A1166C, which leads to enhanced responsiveness of the AT1R, has been postulated as a candidate susceptibility factor for ischemic stroke. The aim of our study was to investigate its occurrence in ischemic stroke and to analyze its possible synergistic associations with clinical risk factors. Genetic and clinical data on 308 consecutive patients with acutely developing ischemic stroke were analyzed. A total of 272 stroke and neuroimaging alteration-free subjects served as a control group. Univariate and logistic regression statistical approaches were used. Alone, the AT1R 1166C allele did not pose a risk of stroke. In hypertensive smokers, however, it was associated with an increased risk of ischemic stroke (OR 22.3, 95% CI 5.8–110.2, p<0.001). Further subgroup analysis revealed the same association for both small-vessel (OR 24.3, 95% CI 6.1–121.1, p<0.001) and large-vessel (OR 21.3, 95% CI 4.6–81.1, p<0.001) infarction. On a pathophysiological basis, our results suggest the possibility that the AT1R A1166C polymorphism might give rise to ischemic stroke indirectly via an unfavorable effect on the cardiorespiratory function.
Article PDF
Similar content being viewed by others
References
Agachan B., Isbir T., Yilmaz H., and Akoglu E. (2003) Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp. Mol. Med. 35, 545–549.
Cheng Z. J., Vapaatalo H. and Mervaala E. (2005) Angiotensin II and vascular inflammation. Med. Sci. Monit. 25, 194–205.
Ferreira A.J. and Santos R.A.S. (2005) Cardiovascular action of angiotensin (1–7). Braz. J. Med. Biol. Res. 38, 499–507.
Fukazawa R., Sonobe T., Hamamato K., Hamaoka K., Sakata K., Asano T., et al. (2004) Possible synergic effect of angiotensin-I converting enzyme insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischaemic heart disease in patients with Kawasaki disease. Pediatr. Res. 56, 597–601.
Henderson S.O., Haiman C.A., and Mack W. (2004) Multiple polymorphisms in the renin-angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am. J. Med. Sci. 328, 266–273.
Hindorff L. A., Heckbert S. R., Tracy R., Tang Z., Psaty B. M., Edwards K. I., et al. (2002) Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am. J. Hypertens. 15, 1050–1056.
Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., et al. (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112–116.
Jones A., Dhamrait S. S., Payne J. R., Hawe E., Li P., Toor I.S., et al. (2003) Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 42, 500–506.
Kobashi G., Hata A., Ohta K., Yamada H., Kato E. H., Minakami H., et al. (2004) A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J. Hum. Genet. 49, 182–186.
Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875–879.
Miller, J. A. and Scholey J. W. (2004) The impact of reninangiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr. Opin. Nephrol. Hypertens. 13, 101–106.
Miller S.A., Dykes D.D., and Polesky H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215–1218.
Munzel T., Daiber A., Ullrich V., and Mulsch A. (2005) Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler. Thromb. Vasc. Biol. 25, 1551–1557.
Nicholls J. and Peiris M. (2005) Good ACE, bad ACE do battle in lung injury, SARS. Nat. Med. 11, 821–822.
Rubattu S., DiAngelantonio E., Stanzione R., Zanda B., Evangelista A., Pirisi A., et al. (2004) Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J. Hypertens. 22, 2129–2134.
Sainani G. S. and Maru V. G. (2004) Role of endothelial cell dysfunction in essential hypertension. J. Assoc. Physicians India 52, 966–969.
Schmieder R. E. (2005) Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am. J. Hypertens. 18, 720–730.
Schram M. T. and Stehouwer C. D. (2005) Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm. Metab. Res. 37, 49–55.
Sugimoto K., Katsuya T., Ohkubo T., Hozawa A., Yamamoto K., Matsuo A., et al. (2004) Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens. Res. 27, 551–556.
Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., and Fodor L. (2002) Evaluation of the interactions of common genetic mutations in stroke subtypes. J. Neurol. 249, 1391–1397.
Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., Fodor L., Bene J., and Melegh B. (2003) Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 74, 1615–1620.
Treszl A., Szabo M., Dunai G., Nobilis A., Kocsis I., Machay T., et al. (2003) Angiotensin II type 1 receptor, a 1166C polymorphism and prophylactic indomethacin treatment induced ductus arterious closure in very low birth weight neonates. Pediatr. Res. 54, 753–755.
Um J. Y., Moon K. S., Lee K. M., Cho K. H., Heo Y., Moon B. S., and Kim H. M. (2003) Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infaction. J. Mol. Neurosci. 21, 23–28.
van Geel P.P., Pinto Y.M., Voors A.A., Buikema H., Oosterga M., Crijns H.J.G.M., and van Gilst W. H. (2000) Angiotenin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35, 717–721.
World Health Organization (1985) Report on diabetes mellitus. World Health Organ. Tech. Rep. Ser. 727.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Szolnoki, Z., Havasi, V., Talián, G. et al. Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers. J Mol Neurosci 28, 285–290 (2006). https://doi.org/10.1385/JMN:28:3:285
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:28:3:285